Who owns IRONWOOD PHARMACEUTICALS INC?
- CUSIP Number: 46333xah1
Tip: Access positions for across all investors
Analyze quarterly positions in Ironwood Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Ironwood Pharmaceuticals stock
Who bought or sold IRONWOOD PHARMACEUTICALS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Braidwell | 53M | $54M | 240% | Mar 2024 |
|
| Wellesley Investment Advisors | 27M | $29B | 100% | Dec 2023 |
|
| D. E. Shaw & Co | 22M | $22M | 100% | Mar 2024 |
|
| Millennium Management | 15M | $15M | 100% | Mar 2024 |
|
| Balyasny Asset Management | 15M | $15M | -41% | Mar 2024 |
|
| Capstone Investment Advisors | 11M | $11M | -29% | Mar 2024 |
|
| Calamos Advisors | 9.5M | $9.7M | 0% | Mar 2024 |
|
| Shenkman Capital Management | 5.9M | $6.2B | 184% | Mar 2024 |
|
| Leucadia National Corporation | 258k | $262k | 529% | Mar 2024 |
|
| Aviva | 250k | $253k | 100% | Mar 2024 |
|
| Bank of New York Mellon | 200k | $202k | 100% | Mar 2024 |
|
| Central Pacific Bank - Trust Division | 179k | $181k | 100% | Mar 2024 |
|
| D.A. Davidson & Co. | 135k | $136k | 0% | Mar 2024 |
|
| Barclays | 92k | $93k | 100% | Mar 2024 |
|
| First Hawaiian Bank | 68k | $69k | 100% | Mar 2024 |
|
| Cetera Investment Advisers | 36k | $37k | 100% | Mar 2024 |
|
| HPM Partners | 18k | $174k | -50% | Mar 2024 |
|
| Foresight Capital Management Advisors | 14k | $14k | -46% | Mar 2024 |
|
| Mason & Associates | 14k | $14k | 100% | Mar 2024 |
|
| Northwestern Mutual Wealth Management Company | 6.0k | $6.1k | 0% | Mar 2024 |
|
| Wells Fargo & Company | 5.0k | $5.1k | 400% | Mar 2024 |
|
Who sold out of Ironwood Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Wolverine Asset Management | Dec 2023 | 34M | $37M |
| Readystate Asset Management | Dec 2023 | 12M | $13M |
| CSS | Dec 2023 | 6.5M | $7.1M |
| Jane Street | Dec 2023 | 3.8M | $4.0M |
| Jpmorgan Chase & Co | Dec 2023 | 2.4M | $2.6M |
| FMR | Sep 2023 | 2.0M | $1.9M |
| Citigroup | Dec 2023 | 249k | $270k |
| Multi-Financial Securities | Sep 2023 | 32k | $31k |
| Morgan Stanley | Sep 2023 | 9.0k | $8.7k |
| Boussard & Gavaudan Investment Management | Sep 2023 | 6.6k | $6.5M |